Unusually Long Survival from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with Antineoplastons in Phase II Studies

Stanislaw R Burzynski,
Gregory S Burzynski,
Tomasz J Janicki,
Radoslaw J Siwiec,
Samuel W Beenken
  10.33425/2692-7918.1112 Published: 12 Sep, 2025

Burzynski SR, Burzynski GS, Janicki TJ, Siwiec RJ, Beenken SW. Unusually Long Survival from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with Antineoplastons in Phase II Studies. Neurol Neurosci. 2025;6(7):036.